Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

5.36
Delayed Data
As of 3:25pm ET
 -0.08 / -1.47%
Today’s Change
5.14
Today|||52-Week Range
14.50
-38.53%
Year-to-Date

Today’s Trading

Previous close5.44
Today’s open5.51
Day’s range5.24 - 5.51
Volume650,522
Average volume (3 months)796,051
Market cap$313.0M
Dividend yield--
Data as of 3:25pm ET, 05/04/2016

Growth & Valuation

Earnings growth (last year)+16.28%
Earnings growth (this year)-28.17%
Earnings growth (next 5 years)--
Revenue growth (last year)+170.69%
P/E ratioNM
Price/Sales21.60
Price/Book2.52

Competitors

 Today’s
change
Today’s
% change
TLGTTeligent Inc-0.16-2.71%
CNCEConcert Pharmaceutic...-0.06-0.44%
MYOKMyoKardia Inc-0.01-0.08%
INFIInfinity Pharmaceuti...-0.31-5.50%
Data as of 3:38pm ET, 05/04/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$20.8M
Annual profit (last year)-$55.7M
Net profit margin-268.55%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
COO, Principal Financial &
Accounting Officer
Joseph P. Hagan
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs